Cannabis Report
Home > Boards > US Listed > Biotechs >

Neurotrope Inc. (NTRP)

NTRP RSS Feed
Add NTRP Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives, runncoach, Cyosol
Search This Board: 
Last Post: 7/15/2018 3:39:34 PM - Followers: 71 - Board type: Free - Posts Today: 2


 

Description:
Neurotrope Bioscience is a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders.

For more information, visit: http://www.neurotropebioscience.com/

Market Information (as of March 31, 2018 unless otherwise stated):
Symbol: NTRP
Market Value:
$64,367,270
Authorized Shares: 150,000,000
Outstanding Shares:
7,907,527
Public Float: 5,900,000
Warrants:
- Series A Warrants to purchase 49,449 shares of our common stock at an exercise price of $0.32 per share, with an expiration date five years from the date of issuance.
- Series C Warrants to purchase 78,616 shares of our common stock at an exercise price of $0.32 per share, with an expiration date of five years from the date of issuance.
- Series E Warrants, which are contingent upon the exercise of the Series C Warrants, to purchase 819,914 shares of our common stock at an exercise price of $32.00 per share, with an expiration date that is five years from the date of the initial exercise of the Series C Warrants.
- Series F Warrants to purchase 3,751,033 shares of our common stock at an exercise price of $12.80 per share, with an expiration date five years from the date of issuance.
- Placement agent warrants to purchase 21,707 shares of our common stock at an exercise price of $0.32 per share.
- Placement agent warrants to purchase 382,887 shares of our common stock at an exercise price of $6.40 per share.
Options outstanding: 1,343,335
Shares after dilution (Outstanding shares + Warrants + Options): 14,354,468
Market value after dilution: $116,845,370

For more information, see the latest annual report here: https://www.sec.gov/Archives/edgar/data/1513856/000114420418013105/tv487391_10k.htm
Presentations:
Alzheimer's Association International Conference 2017: http://www.neurotropebioscience.com/wp-content/assets/NTRP%20Presentation%20AAIC%202017.pdf
Sachs Annual Neuroscience BioPartnering & Investment Forum 2018: http://www.neurotropebioscience.com/wp-content/assets/NTRP%20Presentation%20%287Jan18%29%20Sachs%20Forum.pdf
Noble Conference Alzheimer's Panel 2018: http://noble.mediasite.com/mediasite/Play/911da4f57eff4257a83b9711230158831d?catalog=6f8e7abd-96e3-462f-8035-f48126f80846
Noble Conference Corporate Presentation 2018: http://noble.mediasite.com/mediasite/Play/f9cc934c8a0148f3b6a234de3e4e6f571d?catalog=6f8e7abd-96e3-462f-8035-f48126f80846

Links:
Patents by Daniel L. Alkon: https://patents.justia.com/inventor/daniel-l-alkon
Phase 2a and compassionate use patient results: https://content.iospress.com/articles/journal-of-alzheimers-disease/jad170161?resultNumber=0&totalResults=3&start=0&q=neurotrope&resultsPageSize=10&rows=10
Phase 2b results: https://www.prnewswire.com/news-releases/neurotropes-bryostatin-improves-cognition-in-patients-with-advanced-alzheimers-disease-based-on-further-analysis-of-phase-2-clinical-trial-data-300578025.html
Relevant research articles: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138460239
Roth report: https://www.scribd.com/document/379434551/2018-03-08-NTRP-Roth-Init
Maxim report: https://www.scribd.com/document/379427337/NTRP-initiation
Cannabis Report
NTRP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NTRP News: Neurotrope Appoints Leading Experts in Alzheimer's Disease to its Scientific Advisory Board (SAB) 07/11/2018 08:30:00 AM
NTRP News: Neurotrope to Present Additional Phase 2 Data at the Alzheimer's Association International Conference (AAIC) 2018 Meeting 07/02/2018 08:30:00 AM
NTRP News: Current Report Filing (8-k) 06/22/2018 04:33:07 PM
NTRP News: Confidential Treatment Order (ct Order) 06/06/2018 10:46:12 AM
NTRP News: Quarterly Report (10-q) 05/14/2018 05:19:46 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#5681  Sticky Note Here's the corporate presentation: http://noble.mediasite.com/mediasite/Play/f9 Cyosol 02/05/18 01:55:24 PM
#710  Sticky Note Why I will be watching but not investing XenaLives 02/14/17 10:51:33 AM
#6452   It all depends on timing. I would guess Whatsupp 07/15/18 03:39:34 PM
#6451   They will definitely have to partner with someone Cyosol 07/15/18 07:23:26 AM
#6450   I’ve thought from the 1st day this company Whoopddew 07/14/18 04:59:32 PM
#6449   Company has repeatedly stated they are willing to runncoach 07/14/18 04:26:15 PM
#6448   Question about Capital Raise?? Battle Ready 07/14/18 03:40:50 PM
#6446   That is my prediction, a 25%-30% reduction in Whatsupp 07/14/18 01:32:46 PM
#6445   Can't wait to see some warrants cashed in runncoach 07/13/18 04:28:36 PM
#6444   Hopefully the full results from the last trial Cyosol 07/13/18 04:18:14 PM
#6443   The only thing "stricter" is the non memantine runncoach 07/13/18 04:11:59 PM
#6442   You are correct in the sense that there Cyosol 07/13/18 04:06:46 PM
#6441   Those are very loose estimates on the FDA runncoach 07/13/18 03:58:36 PM
#6440   Estimated study completion date is set for July Cyosol 07/13/18 03:55:59 PM
#6439   Trial time line. runncoach 07/13/18 03:42:32 PM
#6438   You may be right that it's institutional. InTheTrenches 07/13/18 03:15:15 PM
#6437   Not exactly my point. The other trial was runncoach 07/13/18 02:39:35 PM
#6436   WCT is the organization responsible for conducting the Cyosol 07/13/18 02:30:35 PM
#6435   May or may not matter but they had runncoach 07/13/18 02:19:31 PM
#6434   No. The last trial started in November 2015, but Cyosol 07/13/18 01:51:31 PM
#6433   I have wondered this as well. I guess runncoach 07/13/18 01:48:06 PM
#6432   Study start date. Biostudent 07/13/18 01:38:39 PM
#6431   Be a fine end to the week to Whoopddew 07/13/18 12:27:36 PM
#6430   Nice. Probably institutional runncoach 07/13/18 12:08:27 PM
#6429   Maybe it's just an institution desperate to buy Cyosol 07/13/18 12:02:38 PM
#6428   Who knows, but the stock should be Whatsupp 07/13/18 11:53:21 AM
#6427   Nice move on above average volume. InTheTrenches 07/13/18 11:43:51 AM
#6426   Why are we up $1.05? heldnova 07/13/18 11:43:31 AM
#6425   I think you're right on that bio student. runncoach 07/12/18 05:38:26 PM
#6424   I am curious as to: patient dosing for Biostudent 07/12/18 05:32:58 PM
#6423   Just so we're all on the same page, runncoach 07/11/18 08:14:44 PM
#6422   Anxiously awaiting the data presentation Whoopddew 07/11/18 08:04:23 PM
#6421   Yes it is. Solid team runncoach 07/11/18 09:50:08 AM
#6420   Neurotrope Inc. SAB. Good to have them FooBarAndGrill 07/11/18 09:13:55 AM
#6419   https://www.prnewswire.com/news-releases/neurotrope-appoints-leading-experts-in- Cyosol 07/11/18 08:49:50 AM
#6418   LOL - Anavex will be lucky to have Whatsupp 07/10/18 09:34:26 AM
#6417   I've posted time and time again research on runncoach 07/09/18 03:26:54 PM
#6416   Given the historical track record of IGF there XenaLives 07/09/18 03:23:45 PM
#6415   I imagine it would be heavily prescribed off-label runncoach 07/08/18 09:04:14 PM
#6414   Having one of those random thoughts days and Whoopddew 07/08/18 08:50:35 PM
#6413   Leerinks analysts not buying it. https://twitter.com/adamfeuerstein/status/1015 Wildginger 07/06/18 03:27:26 PM
#6412   Until we get a partner or results of runncoach 07/06/18 03:02:38 PM
#6411   Nice little move today on decent volume. runncoach 07/06/18 02:58:36 PM
#6410   No doubt if successful this will be huge Whoopddew 07/06/18 12:25:58 PM
#6409   Just goes to show how desperate the market Cyosol 07/06/18 12:13:57 PM
#6408   I’d take half that and do a happy dance Whoopddew 07/06/18 12:09:29 PM
#6407   Cyosol, forgive me, how ironic that I made Battle Ready 07/06/18 11:58:44 AM
#6406   https://www.cnbc.com/2018/07/06/biogen-shares-soar-on-successful-alzheimers-drug Cyosol 07/06/18 11:51:13 AM
#6405   Cyosol, you are off by a zero, but Battle Ready 07/06/18 11:41:57 AM
#6404   Up 15% now, which means investors have valued Cyosol 07/06/18 11:19:24 AM
#6403   I agree. Doesn't seem to be any InTheTrenches 07/06/18 10:13:33 AM
#6402   Yeah i saw that. Another potential slowing of runncoach 07/06/18 09:40:55 AM
PostSubject